Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Vaccine

Adolescents aged 12 to 15 at risk of severe disease able to get COVID-19 booster after government accepts latest ATAGI advice

Australian teenagers aged 12-15 who are at risk of severe disease will be able to receive a COVID-19 booster shot from as early as next week.

ABC News

Northern Territory scraps vaccine mandate for workers, Chief Minister Natasha Fyles confirms

Prior to today's announcement, people in the Northern Territory who worked in a wide range of industries — including teachers, hospitality workers and beauticians — needed all three COVID-19 vaccines to go into the office.

ABC News

Scientists want to know whether meningococcal B vaccines could protect against gonorrhoea

The vaccine against the B strain is not available to most children and adolescents free of charge but a researcher says new trials could change its cost-effectiveness.

ABC News

From analysis to the latest developments in health,
read the most diverse news in one place.

Breakthrough vaccine raises hopes of pancreatic cancer cure

Experts say vaccines could train the immune system to kill cells associated with pancreatic cancer

Wales Online

HC Wainwright Says Non-mRNA COVID-19 Option Underappreciated

HC Wainwright says safety concerns were noted for Novavax Inc's (NASDAQ: NVAX) COVID-19 vaccine, but the strength of data showed that benefit outweighs risks.

Benzinga

Trials of new COVID vaccine raise hopes of once-a-year booster

Moderna shot is said to produce eightfold increase in antibody levels against Omicron in first four weeks

The Guardian - UK

Here's What To Watch On Novavax Stock As Latest COVID-19 Vaccine Gains Approval

Novavax, Inc (NASDAQ: NVAX) gapped up 10% to start the trading day on Wednesday, but at press time, the stock had given back almost all of its gains to trade mostly flat.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Monkeypox needs 'substantial public health response' warns Covid expert

While the virus does not spread as easily as Covid-19 it still needs to be tackled correctly

Wales Online

Moderna vaccine trial raises hopes of yearly Covid booster

People who received vaccine showed significant jump in antibody levels compared to original Moderna jab

The Independent UK

Why This Novavax Analyst Remains Bearish After COVID Vaccine Panel Vote

A Bank of America analyst remains bearish on Novavax, Inc (NASDAQ: NVAX) after a regulatory panel approved Novavax’s Emergency Use Authorization request fo

Benzinga

Monkeypox needs ‘substantial public health response’, says Covid vaccine expert

Professor Sir Andrew Pollard was speaking after being knighted by the Prince of Wales at Windsor Castle.

The Independent UK

Moderna’s omicron-targeted shot bolsters antibodies in trial

Moderna Inc. said its COVID-19 vaccine that targets omicron generated a “superior” immune response against the variant compared to its original shot in a widely awaited study that could pave the way for another round of boosters in the fall.

Tribune News Service

US diverts COVID-19 funds to secure vaccines amid stalemate

More than $10 billion in coronavirus relief funds is being diverted from orders of at-home rapid tests and other pandemic-related efforts

The Independent UK

The Daily Biotech Pulse: FDA Adcomm Backing For Novavax's COVID-19 Shot, New Data On Moderna's Omicron Vaccine, DBV Tech's Encouraging Peanut Allergy Trial Data

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Axios

Moderna booster update for Omicron variant could be available late summer

The booster contains the original vaccine with an updated version that specifically targets the Omicron variant.

Benzinga

Why Novavax Stock Is Trading Higher Today

Novavax Inc (NASDAQ: NVAX) shares are trading higher Wednesday after a committee of independent U.S. Food and Drug Administration (FDA) vaccine advisors voted to recommend Novavax's COVID-19 vaccine for Emergency Use Authorization (EUA).

Benzinga

Morning Brief: Top Financial Stories Dominating on Wednesday, June 8

CNBC

Benzinga

What's Next For Novavax Stock As COVID Vaccine Clears Key Hurdle In US

After last week's scare stirred by the release of the Food And Drug Administration's briefing documents, Novavax (NASDAQ: NVAX) can now heave a sigh of relief.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Moderna announces promising results from next-generation Covid vaccine trials

Experts hope the newer jabs could protect against a wider range of variants.

WEKU

Moderna says its new vaccine booster shows 'superior' response to omicron

The "bivalent" vaccine — meaning it targets two different antigens — is Moderna's leading candidate for an effective booster this fall. If the data pan out, it could lead to a yearly booster.

The Independent UK

Moderna says updated COVID shot boosts omicron protection

Moderna says its experimental COVID-19 vaccine that combines its original shot with protection against the omicron variant appears to work

Asharq Al-Awsat

Moderna Says Omicron-Specific Booster Generates Strong Immune Response

Moderna Inc said on Wednesday its COVID-19 vaccine booster that targets both the original coronavirus strain and Omicron produced a better immune response against the variant than its original vaccine. The booster raised virus-neutralizing antibodies by eight-fold in a study.

Reuters

Moderna says Omicron-targeted COVID shot shows better response

Moderna Inc said on Wednesday a new version of its coronavirus vaccine produced a better immune response against Omicron than the original shot, as the drugmaker pursues a booster against a surge in infections in the fall season.

Benzinga

COVID-19 Vaccine Patent Waiver Expected Soon, Says WTO Head: Reuters

In a telephone interview with Reuters, WTO's Director-General Ngozi Okonjo-Iweala, an agreement on waiving intellectual property rights for COVID-19 vaccines is within reach. A key World Trade Organization (WTO) meeting is scheduled next week to discuss the COVID-19 vaccine patent waiver debate. "If we get one or two deliverables, that…

The Independent UK

Breakthrough vaccine could help cure pancreatic cancer

Early trial results suggest personalised vaccines could stop deadly disease returning

1 … 256 257 258 259

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Intellectual Property

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.